News|Articles|February 2, 2005

Pharmaceutical Technology

  • Pharmaceutical Technology-02-02-2005
  • Volume 29
  • Issue 2

Contract Manufacturers Getting Squeezed

Author(s)Jim Miller

Too many players and threats to the main customer base challenge European dose manufacturers.


Related to this article

CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.